The second COVID peak is here, but there’s a silver lining

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

 

In Australia, the Omicron BA2 subvariant has essentially replaced BA1 as the cause of the current cases of COVID, says Professor Kristine Macartney.

Speaking on Healthed’s latest webcast, Professor Macartney from the National Centre for Immunisation, Research and Surveillance, said two years into the pandemic we are currently experiencing our second peak, with record-high numbers of cases per 100,000 people being diagnosed But fortunately the current Omicron infection does not appear as severe as the original SARS-CoV-2 strains.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Cheng

A/Prof Daryl Cheng

RSV Prevention in Infants and Pregnant Women

Prof Jason Ong

Prof Jason Ong

STIs – Common and Tricky Cases

Dr Terri Foran

Dr Terri Foran

Role of Testosterone During Menopause - Evidence vs Hype

Dr Fiona Chan

Dr Fiona Chan

Vision and Driving Fitness: Key Insights for Health Practitioners

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

Has a clinic you work at ever received an unfair negative online review?

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease